Alison Roxby, MD, MSc

Associate Professor, Medicine, Global Health

Alison Roxby MD, MSc, is an Associate Professor jointly appointed in the Departments of Medicine and Global Health. She received her MD degree from UNC-Chapel Hill and a Master’s of Science in Public Health from the London School of Hygiene and Tropical Medicine. She has worked in 5 different African countries to improve access to HIV care and prevent HIV transmission. Alison lived in Nairobi from 2009-2010, where she was a Fogarty International Clinical Research Fellow and served as the study physician for the Valacyclovir in Pregnancy trial. Alison currently holds an R01 award from NICHD titled, “Incident STIs in Kenyan Girls: a prospective cohort spanning sexual debut," and an R21 award from NIAID titled, “DMPA use and vaginal bacterial diversity among African women.” Her research studies the interaction of contraceptives and sexually transmitted infections in women. She has been heavily involved in training grants to improve representation of African colleagues in research and leadership, including co-leading a Scientific Working Group and Early stage Investigator Mentoring group with the Center for AIDS Research. She also sees adult HIV patients at Madison Clinic and is the Clinic Director of the Roosevelt Virology Clinic at UWMC. In 2020, she began to work in COVID-19 studying key populations in the King County area, including residents of nursing facilities and the workers who care for them, and joined the Coronavirus Prevention Network (CoVPN) at Fred Hutch to help ensure adequate representation of key populations in Coronavirus prevention clinical trials.

 

Publications

  1. Cantos, VD, Neradilek, M, Huang, Y, Roxby, AC, Gillespie, K, deCamp, AC et al.. Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials. Open Forum Infect Dis. 2024;11 (7):ofae387. doi: 10.1093/ofid/ofae387. PubMed PMID:39035572 PubMed Central PMC11259185.
  2. Chihana, R, Jin Kee, J, Moodie, Z, Huang, Y, Janes, H, Dadabhai, S et al.. Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine. 2024; :. doi: 10.1016/j.vaccine.2024.05.039. PubMed PMID:38772835 .
  3. Hybiske, K, Paktinat, S, Newman, K, Patton, D, Khosropour, C, Roxby, AC et al.. Antibodies from chlamydia-infected individuals facilitate phagocytosis via Fc receptors. Infect Immun. 2024;92 (4):e0050323. doi: 10.1128/iai.00503-23. PubMed PMID:38451079 PubMed Central PMC11003224.
  4. Kopp, CM, Sobhani, NC, Baker, B, Tapia, K, Jain, R, Hitti, J et al.. Antiretroviral Regimen and Pregnancy Outcomes of Women Living with HIV in a US Cohort. Infect Dis Clin Pract (Baltim Md). 2023;31 (6):. doi: 10.1097/IPC.0000000000001308. PubMed PMID:38213314 PubMed Central PMC10781410.
  5. Oluoch, L, Tapia, K, Kiptinness, C, Casmir, E, Maina, SG, Makena, L et al.. Longitudinal assessment of bacterial vaginosis prior to and during incident pregnancy: an observational study in Kenyan adolescent girls and young women. BMJ Open. 2023;13 (10):e071746. doi: 10.1136/bmjopen-2023-071746. PubMed PMID:37813538 PubMed Central PMC10565234.
Search PubMed

Comments are closed.